Sequent Scientific Limited (NSE:SEQUENT)
173.92
-0.91 (-0.52%)
Aug 26, 2025, 3:29 PM IST
Sequent Scientific Market Cap
Sequent Scientific has a market cap or net worth of 43.47 billion as of August 26, 2025. Its market cap has increased by 29.05% in one year.
Market Cap
43.47B
Enterprise Value
48.31B
Revenue
16.03B
Ranking
n/a
PE Ratio
146.49
Stock Price
173.92
Market Cap Chart
Since January 5, 2005, Sequent Scientific's market cap has increased from 347.75M to 43.47B, an increase of 12,401.52%. That is a compound annual growth rate of 26.34%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 26, 2025 | 43.47B | -1.15% |
Dec 31, 2024 | 43.98B | 55.47% |
Dec 29, 2023 | 28.29B | 29.89% |
Dec 30, 2022 | 21.78B | -45.17% |
Dec 31, 2021 | 39.72B | -4.29% |
Dec 31, 2020 | 41.50B | 140.82% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Sun Pharmaceutical Industries | 3,974.98B |
Divi's Laboratories | 1,658.78B |
Cipla | 1,293.38B |
Apollo Hospitals Enterprise | 1,128.85B |
Mankind Pharma | 1,055.39B |
Zydus Lifesciences | 1,029.53B |
Fortis Healthcare | 690.90B |
Alkem Laboratories | 647.50B |